Source comparison
MOTS-c vs Tesofensine — Metabolic Peptide Comparison | Real Peptides
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondrially-encoded peptide consisting of 16 amino acids that directly influences nuclear gene expression to improve insulin sensitivity and metabolic flexibility. Tesofensine is a triple mon
This comparison does not assign a generated winner or score.
- MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondrially-encoded peptide consisting of 16 amino acids that directly influences nuclear gene expression to improve insulin sensitivity and metabolic flexibility. Tesofensine is a triple monoamine reuptake inhibitor originally developed as an anti-Parkinson medication that suppresses appetite by blocking dopamine, norepinephrine, and serotonin reuptake in the CNS. The difference between MOTS-c and Tesofensine isn't subtle. They operate through entirely distinct biological pathways with no mechanistic overlap.
- We've seen researchers incorrectly assume these compounds can be used interchangeably in metabolic research protocols. They can't. One acts on mitochondrial biogenesis and energy substrate selection; the other acts on synaptic neurotransmitter availability. Choosing between them requires understanding whether your research question involves cellular energy production or central nervous system appetite regulation.
- What's the core difference between MOTS-c and Tesofensine?
- MOTS-c is a mitochondrial-derived peptide that translocates to the nucleus during metabolic stress, upregulating genes involved in glucose metabolism and oxidative phosphorylation. It improves how cells produce and use energy. Tesofensine is a synthetic small molecule that inhibits the reuptake of dopamine, norepinephrine, and serotonin, reducing caloric intake by 20–30% through CNS-mediated appetite suppression. MOTS-c targets metabolic efficiency at the cellular level; Tesofensine targets feeding behavior through neurotransmitter modulation.
- The confusion stems from both being studied in metabolic contexts. But MOTS-c doesn't suppress appetite directly, and Tesofensine doesn't improve mitochondrial function. MOTS-c activates AMPK (AMP-activated protein kinase) pathways that shift substrate preference from glucose to fatty acids during exercise or caloric restriction. Tesofensine blocks monoamine transporters (DAT, NET, SERT) at nanomolar concentrations, extending the duration dopamine and norepinephrine remain in synaptic clefts. Which reduces hunger signaling from the hypothalamus. This article covers the structural and pharmacological differences, research applications where each compound excels, and why mixing them in stacked protocols introduces contradictory signaling pathways.